A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia

Franco Mandelli, Maria Concetta Petti, Alfredo Ardia, +14

European Journal of Cancer and Clinical Oncology

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology +6

Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies.

Angelo Michele Carella, Ellin Berman, M. P. Maraone, +1

PubMed

Mixed-phenotype Acute LeukemiaImmunologyPharmacotherapyAntimicrobial ChemotherapyDrug Resistance +17

Clinical Toxicity of 4′-Epi-Doxorubicin (Epirubicin)

Fabrizio Ganzina, Nicola Di Pietro, Osvaldo Magni

Tumori Journal

Functional AssessmentHeart FailureOncologyCardiovascular DiseaseMedicine +13

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology

V. Tamassia, Agatino Battaglia, Fabrizio Ganzina, +7

Cancer Chemotherapy and Pharmacology

Medroxyprogesterone AcetateOncologyPharmacological StudyPharmacologyPharmacotherapy +5

Phase II trial with oral idarubicin in advanced breast cancer

Massimo Lopez, Luigi Di Lauro, Paola Papaldo, +3

Investigational New Drugs

Breast OncologyMedicinePharmacologyOral IdarubicinBreast Cancer +4

Clinical evaluation of 4′-epi-doxorubicin in advanced solid tumors

G. Robustelli della Cuna, Lorenzo Pavesi, Piero Preti, +1

Investigational New Drugs

Tumoral PathologyMedicinePathologyAdvanced Solid TumorsOncology +1

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia

Giorgio Lambertenghi‐Deliliers, Anna Teresa Maiolo, C. Annaloro, +4

European Journal of Cancer and Clinical Oncology

Hematological MalignancyOncologySequential CombinationMedicineMixed-phenotype Acute Leukemia +9

Caerulein (ceruletide). A review.

Fabrizio Ganzina, Ana Santamaria

Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

PharmacologyPharmacotherapyMedicineAntiparasitic Agent

Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.

P Hurteloup, Fabrizio Ganzina

PubMed

Medicinal ChemistryAntifungal AgentOncologyAntibioticsAnalogue Development +13

Phase II Study of 4'Epi-Doxorubicin

Eros Ferrazzí, Ornella Nicoletto, Orazio Vinante, +4

Tumori Journal

X-ray CrystallographyPharmaceutical ScienceHeart FailureCardiac AnaesthesiaNew Analogue +17